PK and YOU
At Takeda, we are committed to helping people take a personalized approach to living with hemophilia A
Each individual has a unique way that their body processes and clears Factor VIII (FVIII), an essential blood clotting protein.
Prophylactic FVIII replacement is a course of treatment taken regularly to prevent bleeds.
Managing hemophilia A through FVIII is considered the standard of care for people living with severe hemophilia A.
A 'one-size-fits-all' approach to prophylaxis is not ideal. The same dose and frequency for different people could potentially lead to over-treatment in some individuals and under-treatment in others.
It is important to have a personalized approach to prophylaxis to achieve an optimal FVIII that remains above a certain threshold that is determined by your healthcare provider.
See how therapy should be tailored to your personal and medical needs.